search
Back to results

Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

Primary Purpose

Lumbar Spondylolisthesis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Posterior lumbar interbody fusion
Inter transverse bone grafting
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Spondylolisthesis

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • lumbar spondylolisthesis

Exclusion Criteria:

  • infection of lumbar spine

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Lumbar spondylolisthesis1

    Lumbar spondylolisthesis 2

    Arm Description

    Outcomes

    Primary Outcome Measures

    Back pain
    Back pain severity grading mild, moderate, severe

    Secondary Outcome Measures

    Full Information

    First Posted
    August 31, 2017
    Last Updated
    August 31, 2017
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03271060
    Brief Title
    Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis
    Official Title
    Comparative Study Between Posterior Lumbar Interbody Fusion(PLF) and Intertransverse Process Fusion in Treatment of Spodylolithesis
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 1, 2017 (Anticipated)
    Primary Completion Date
    August 30, 2018 (Anticipated)
    Study Completion Date
    September 1, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The first technique described for interbody fusion was the anterior lumbar interbody fusion (ALIF).(20) For this technique, the intervertebral disc is accessed through a retroperitoneal or transperitoneal approach. While the posterior approach was first described by Russell Hibbs in 1911, in the 1950's, Cloward (7)popularized the posterior approach for a posterior lumbar interbody fusion (PLIF).
    Detailed Description
    In this study we will try to identify the benefits and outcome of posterior lumbar interbody fusion and inter transverse process bone graft fusion.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lumbar Spondylolisthesis

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Posterior inter body fusion and inter transverse process bone graft
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Lumbar spondylolisthesis1
    Arm Type
    Active Comparator
    Arm Title
    Lumbar spondylolisthesis 2
    Arm Type
    Active Comparator
    Intervention Type
    Procedure
    Intervention Name(s)
    Posterior lumbar interbody fusion
    Intervention Description
    Lumbar fusion by screws and inter vertebral cage
    Intervention Type
    Procedure
    Intervention Name(s)
    Inter transverse bone grafting
    Intervention Description
    Inter transverse process bone grafting by bone graft from illiac crest or other sites
    Primary Outcome Measure Information:
    Title
    Back pain
    Description
    Back pain severity grading mild, moderate, severe
    Time Frame
    1year postoperative

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: lumbar spondylolisthesis Exclusion Criteria: infection of lumbar spine
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Mahmoud Garamoun, Resident
    Phone
    201091123869
    Email
    Garamoun.mahmoud@yahoo.com

    12. IPD Sharing Statement

    Learn more about this trial

    Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

    We'll reach out to this number within 24 hrs